Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
When Prostate Cancer Circulates in the Bloodstream.
Vlaeminck-Guillem V. Vlaeminck-Guillem V. Diagnostics (Basel). 2015 Oct 29;5(4):428-74. doi: 10.3390/diagnostics5040428. Diagnostics (Basel). 2015. PMID: 26854164 Free PMC article. Review.
Exosomes and prostate cancer management.
Vlaeminck-Guillem V. Vlaeminck-Guillem V. Semin Cancer Biol. 2022 Nov;86(Pt 1):101-111. doi: 10.1016/j.semcancer.2021.08.004. Epub 2021 Aug 9. Semin Cancer Biol. 2022. PMID: 34384877 Review.
SRC: marker or actor in prostate cancer aggressiveness.
Vlaeminck-Guillem V, Gillet G, Rimokh R. Vlaeminck-Guillem V, et al. Front Oncol. 2014 Aug 18;4:222. doi: 10.3389/fonc.2014.00222. eCollection 2014. Front Oncol. 2014. PMID: 25184116 Free PMC article. Review.
Urinary PCA3 score predicts prostate cancer multifocality.
Vlaeminck-Guillem V, Devonec M, Colombel M, Rodriguez-Lafrasse C, Decaussin-Petrucci M, Ruffion A. Vlaeminck-Guillem V, et al. J Urol. 2011 Apr;185(4):1234-9. doi: 10.1016/j.juro.2010.11.072. Epub 2011 Feb 22. J Urol. 2011. PMID: 21334023
Urinary prostate cancer 3 test: toward the age of reason?
Vlaeminck-Guillem V, Ruffion A, André J, Devonec M, Paparel P. Vlaeminck-Guillem V, et al. Urology. 2010 Feb;75(2):447-53. doi: 10.1016/j.urology.2009.03.046. Epub 2009 Jul 8. Urology. 2010. PMID: 19586654 Review.
Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients.
Vlaeminck-Guillem V, Devonec M, Champetier D, Decaussi-Petrucci M, Paparel P, Perrin P, Ruffion A. Vlaeminck-Guillem V, et al. Prog Urol. 2015 Dec;25(16):1160-8, e1-8. doi: 10.1016/j.purol.2015.08.005. Epub 2015 Sep 12. Prog Urol. 2015. PMID: 26376283 English, French.
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients.
Maillet D, Allioli N, Peron J, Plesa A, Decaussin-Petrucci M, Tartas S, Ruffion A, Crouzet S, Rimokh R, Gillet PG, Freyer G, Vlaeminck-Guillem V. Maillet D, et al. Eur Urol Oncol. 2021 Aug;4(4):609-617. doi: 10.1016/j.euo.2019.08.010. Epub 2019 Oct 31. Eur Urol Oncol. 2021. PMID: 31676281
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.
Maillet D, Allioli N, Péron J, Plesa A, Decaussin-Petrucci M, Tartas S, Sajous C, Ruffion A, Crouzet S, Freyer G, Vlaeminck-Guillem V. Maillet D, et al. Among authors: vlaeminck guillem v. Cancers (Basel). 2021 Nov 29;13(23):6014. doi: 10.3390/cancers13236014. Cancers (Basel). 2021. PMID: 34885125 Free PMC article.
67 results